235 related articles for article (PubMed ID: 11487448)
21. [Niacin--an additive therapeutic approach for optimizing lipid profile].
Wieneke H; Schmermund A; Erbel R
Med Klin (Munich); 2005 Apr; 100(4):186-92. PubMed ID: 15834527
[TBL] [Abstract][Full Text] [Related]
22. Existing and investigational combination drug therapy for high-density lipoprotein cholesterol.
Bays H
Am J Cardiol; 2002 Nov; 90(10B):30K-43K. PubMed ID: 12467938
[TBL] [Abstract][Full Text] [Related]
23. An ounce of prevention. Drugs used to treat hyperlipidemia (Part 1).
Turkoski BB
Orthop Nurs; 2004; 23(1):58-61. PubMed ID: 14999954
[TBL] [Abstract][Full Text] [Related]
24. Cholesterol lowering in diabetes. New evidence supports aggressive LDL-C targets.
Rosenson RS
Postgrad Med; 2005 Apr; 117(4):17-20, 23-7. PubMed ID: 15842129
[TBL] [Abstract][Full Text] [Related]
25. The therapeutic role of niacin in dyslipidemia management.
Boden WE; Sidhu MS; Toth PP
J Cardiovasc Pharmacol Ther; 2014 Mar; 19(2):141-58. PubMed ID: 24363242
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic implications of recent ATP III guidelines and the important role of combination therapy in total dyslipidemia management.
Boden WE
Curr Opin Cardiol; 2003 Jul; 18(4):278-85. PubMed ID: 12858126
[TBL] [Abstract][Full Text] [Related]
27. Perspectives in the treatment of dyslipidemias in the prevention of coronary heart disease.
Borgia MC; Medici F
Angiology; 1998 May; 49(5):339-48. PubMed ID: 9591525
[TBL] [Abstract][Full Text] [Related]
28. [Efficacy and safety of combined statin-fenofibrates therapy compared with monotherapy in patients with mixed hyperlipidemia and high risk of coronary heart disease].
Kłosiewicz-Latoszek L; Respondek W; Białobrzeska-Paluszkiewicz J; Grzybowska B; Jakóbisiak-Ostasz B; Stolarska I
Pol Merkur Lekarski; 2003 Jul; 15(85):42-6. PubMed ID: 14593958
[TBL] [Abstract][Full Text] [Related]
29. 'Trig-onometry': non-high-density lipoprotein cholesterol as a therapeutic target in dyslipidaemia.
Jacobson TA
Int J Clin Pract; 2011 Jan; 65(1):82-101. PubMed ID: 21105969
[TBL] [Abstract][Full Text] [Related]
30. Therapy to reduce risk of coronary heart disease.
Rader DJ
Clin Cardiol; 2003 Jan; 26(1):2-8. PubMed ID: 12539806
[TBL] [Abstract][Full Text] [Related]
31. Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.
Evans M; Roberts A; Davies S; Rees A
Drugs; 2004; 64(11):1181-96. PubMed ID: 15161326
[TBL] [Abstract][Full Text] [Related]
32. Epidemiology and management of hyperlipidemia.
Karr S
Am J Manag Care; 2017 Jun; 23(9 Suppl):S139-S148. PubMed ID: 28978219
[TBL] [Abstract][Full Text] [Related]
33. Identifying patients at risk for coronary heart disease: implications from trials of lipid-lowering drug therapy.
Isles CG; Paterson JR
QJM; 2000 Sep; 93(9):567-74. PubMed ID: 10984551
[TBL] [Abstract][Full Text] [Related]
34. Niacin in the Treatment of Hyperlipidemias in Light of New Clinical Trials: Has Niacin Lost its Place?
Zeman M; Vecka M; Perlík F; Hromádka R; Staňková B; Tvrzická E; Žák A
Med Sci Monit; 2015 Jul; 21():2156-62. PubMed ID: 26210594
[TBL] [Abstract][Full Text] [Related]
35. Should pediatric patients with hyperlipidemia receive drug therapy?
Bhatnagar D
Paediatr Drugs; 2002; 4(4):223-30. PubMed ID: 11960511
[TBL] [Abstract][Full Text] [Related]
36. Management of protease inhibitor-associated hyperlipidemia.
Penzak SR; Chuck SK
Am J Cardiovasc Drugs; 2002; 2(2):91-106. PubMed ID: 14727985
[TBL] [Abstract][Full Text] [Related]
37. Advances in the understanding and management of dyslipidemia: using niacin-based therapies.
Ito MK
Am J Health Syst Pharm; 2003 Jul; 60(13 Suppl 2):S15-21; quiz S25. PubMed ID: 12901026
[TBL] [Abstract][Full Text] [Related]
38. Effects of modifying triglycerides and triglyceride-rich lipoproteins on cardiovascular outcomes.
Abdel-Maksoud M; Sazonov V; Gutkin SW; Hokanson JE
J Cardiovasc Pharmacol; 2008 Apr; 51(4):331-51. PubMed ID: 18427276
[TBL] [Abstract][Full Text] [Related]
39. Combination niacin and statin therapy in primary and secondary prevention of cardiovascular disease.
Levy DR; Pearson TA
Clin Cardiol; 2005 Jul; 28(7):317-20. PubMed ID: 16075823
[TBL] [Abstract][Full Text] [Related]
40. Pharmacologic treatment of type 2 diabetic dyslipidemia.
Moon YS; Kashyap ML
Pharmacotherapy; 2004 Dec; 24(12):1692-713. PubMed ID: 15585439
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
